Cordonnier Michael 4

What Happened

Michael Cordonnier, CEO, President and Director of CARLSMED, received an award of 117,316 restricted stock units (RSUs) on January 28, 2026. The Form 4 reports the RSUs at an acquisition price of $0.00 (code A — award/grant). These RSUs are a compensation grant, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-01-28; Form 4 filed: 2026-01-30.
• Transaction type/code: Award/Grant (A). Reported acquisition price: $0.00 per RSU.
• Shares/units granted: 117,316 RSUs.
• Shares owned after transaction: Not specified in the filing.
• Footnote: Each RSU represents a contingent right to one share; vesting in three equal annual installments beginning on the first anniversary of the grant date.
• Timeliness: Filing appears timely (reported two days after the grant).

Context

RSUs are a form of equity compensation that convert into actual shares only as they vest — in this case over three years starting one year after the grant — so Cordonnier did not receive tradable shares immediately. Grants like this are routine for executives and reflect compensation, not necessarily a direct signal of buying or selling sentiment.